Related Experiment Video
Updated: Jul 20, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
Published on: July 30, 2020
A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity
Yun Li1, Gary D Kao, Benjamin A Garcia
1Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.
Abstract:
Histone deacetylase (HDAC) inhibitors perturb the cell cycle and have great potential as anti-cancer agents, but their mechanism of action is not well established. HDACs classically function as repressors of gene expression, tethered to sequence-specific transcription factors. Here we report that HDAC3 is a critical, transcription-independent regulator of mitosis. HDAC3 forms a complex with A-Kinase-Anchoring Proteins AKAP95 and HA95, which are targeted to mitotic chromosomes. Deacetylation of H3 in mitosis requires AKAP95/HA95 and HDAC3 and provides a hypoacetylated H3 tail that is the preferred substrate for Aurora B kinase. Phosphorylation of H3S10 by Aurora B leads to dissociation of HP1 proteins from methylated H3K9 residues on mitotic heterochromatin. This transcription-independent pathway, involving interdependent changes in histone modification and protein association, is required for normal progression through mitosis and is an unexpected target of HDAC inhibitors, a class of drugs currently in clinical trials for treating cancer.
Insights
Histone deacetylase 3 (HDAC3) regulates mitosis independently of transcription. This pathway, involving histone modifications and protein interactions, is a novel target for HDAC inhibitors used in cancer therapy.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Histone deacetylase (HDAC) inhibitors show promise as anti-cancer agents, but their precise mechanisms remain unclear.
- HDACs typically repress gene expression by associating with transcription factors.
Purpose of the Study:
- To elucidate the role of HDAC3 in cell cycle regulation and mitosis.
- To identify the molecular targets and pathways affected by HDAC3 during mitosis.
- To explore the potential of HDAC3 as a therapeutic target in cancer treatment.
Main Methods:
- Investigated the interaction of HDAC3 with A-Kinase-Anchoring Proteins (AKAP95 and HA95) on mitotic chromosomes.
- Analyzed the deacetylation of histone H3 by HDAC3 in mitosis.
- Examined the phosphorylation of H3S10 by Aurora B kinase and its effect on HP1 protein dissociation from heterochromatin.
Main Results:
- HDAC3 functions as a critical, transcription-independent regulator of mitosis.
- HDAC3 forms a complex with AKAP95 and HA95, which localize to mitotic chromosomes.
- Deacetylation of histone H3 by HDAC3 creates a hypoacetylated tail, a preferred substrate for Aurora B kinase.
- Aurora B-mediated phosphorylation of H3S10 causes HP1 dissociation from mitotic heterochromatin.
- This pathway is essential for proper mitotic progression.
Conclusions:
- HDAC3 plays a vital role in mitosis through a transcription-independent mechanism.
- The identified pathway involving histone modifications and protein associations represents an unexpected target for HDAC inhibitors.
- These findings offer new insights into the anti-cancer mechanisms of HDAC inhibitors and suggest potential therapeutic strategies.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
07:14Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
Published on: September 20, 2019
Related Concept Videos
Anaphase Promoting Complex
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Inhibition of Cdk Activity